Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Mar. 31, 2019
Current assets:
Cash & cash equivalents	$ 410,405	$ 3,409
Accounts receivable, net of allowance for doubtful accounts	740,105
Contract assets	132,704
Due from Joint Venture		373
Prepaid expenses and other current assets	117,495
Income taxes receivable	472	1,781
Total current assets	1,401,181	5,563
Property and equipment, net	206,196
Goodwill	3,795,325
Intangible assets, net	4,365,806
Dividend receivable		81,264
Investment in the Joint Venture		1,211,996
Investment in business purchase option	146,500
Other noncurrent assets, net	192,372
Total assets	10,107,380	1,298,823
Current liabilities:
Accounts payable	68,169
Accrued expenses	390,294	176
Deferred revenues	302,313
Due to related parties, net	20,234
Current portion of long-term debt	278,779
Due to the Joint Venture		6,167
Total current liabilities	1,059,789	6,343
Long-term debt, excluding current portion	4,710,294
Deferred income tax liabilities	615,904	159,993
Tax receivable agreement obligations to related parties	177,826
Tax receivable agreement obligation	164,633
Other long-term liabilities	93,487
Total liabilities	6,821,933	166,336
Commitments and contingencies
Stockholders' Equity:
Preferred stock (par value, $.001), 900,000,000 and 0 shares authorized and no shares issued and outstanding at March 31, 2020 and 2019, respectively
Additional paid-in capital	4,222,580	1,153,509
Accumulated other comprehensive income (loss)	(7,372)	(3,256)
Accumultaed deficit	(930,064)	(17,841)
Total stockholders' equity	3,285,447	1,132,487
Total liabilities and stockholders' equity	10,107,380	1,298,823
Common Class X [Member]
Stockholders' Equity:
Common Stock
Common Stock [Member]
Stockholders' Equity:
Common Stock	303	75
Total stockholders' equity	$ 303	$ 75